Clinico-social factors to choose radioactive iodine dose in differentiated thyroid cancer patients: an Asian survey
Conclusion
Different RAI dose ranges are used in the low-risk group probably because the enrolled physicians consider RAI dose elevation on the basis of clinico-social factors beyond pre-existed guidelines. Our study may enable closer harmonization of RAI therapy practice in Asian countries.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Iodine | Nuclear Medicine | PET Scan | Study | Thyroid | Thyroid Cancer | Ultrasound